References
- Blanc C, Deveraux QL, Krajewski S, et al (2000). Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res, 60, 4386-90.
- Bursch W, Karwan A, Mayer M, et al (2008). Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology, 254, 147-57. https://doi.org/10.1016/j.tox.2008.07.048
- De Maria S, Pannone G, Bufo P, et al (2009). Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol, 135, 107-16. https://doi.org/10.1007/s00432-008-0433-z
- Fraunholz I, Rodel C, Distel L, et al (2012). High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy. Radiat Oncol, 7, 88. https://doi.org/10.1186/1748-717X-7-88
- Gibson S, Shillitoe EJ(2006). Analysis of apoptosis-associated genes and pathways in oral cancer cells. J Oral Pathol Med, 35, 146-54. https://doi.org/10.1111/j.1600-0714.2006.00398.x
- Gomes TS, Oshima CT, Segreto HR, et al (2011). The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray. Pathol Res Pract, 207, 613-7. https://doi.org/10.1016/j.prp.2011.06.010
- Grutter MG (2000). Caspases: key players in programmed cell death. Curr Opin Struct Biol, 10, 649-55. https://doi.org/10.1016/S0959-440X(00)00146-9
- Halasova E, Adamkov M, Matakova T, et al (2012). Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma. Adv Exp Med Biol, 756, 15-21.
- Kanwar JR, Kamalapuram SK, Kanwar RK (2012). Survivin Signaling in Clinical Oncology: A Multifaceted Dragon. Med Res Rev. doi: 10.1002/med.21264.
- Khan Z, Tiwari RP, Mulherkar R, et al (2009). Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Head Neck, 31, 1039-48. https://doi.org/10.1002/hed.21071
- Kim WH, Yeo M, Kim MS, et al (2000). Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int J Colorectal Dis, 15, 105-11. https://doi.org/10.1007/s003840050242
- Ko SY, Dass CR, Nurgali K (2012). Netrin-1 in the developing enteric nervous system and colorectal cancer. Trends Mol Med, 18, 544-54. https://doi.org/10.1016/j.molmed.2012.07.001
- Li J, Chen P, Li XQ, et al (2012). Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer. Int J Cancer. doi: 10.1002/ijc.27757.
- Loncarevic S, Vignjevic S, Jovic N, et al (2012). Significance of pathohistological findings and the expression of Bcl-2 in diagnosis and treatment of oral planocellular carcinoma. Vojnosanit Pregl, 69, 314-9. https://doi.org/10.2298/VSP1204314L
- Malaguarnera R, Morcavallo A, Belfiore A (2012). The insulin and igf-I pathway in endocrine glands carcinogenesis. J Oncol, 2012, 635614.
- Mangiola A, Lama G, Giannitelli C, et al (2008). Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res, 13, 6970-7.
- McKenzie JA, Grossman D (2012). Role of the apoptotic and mitotic regulator survivin in melanoma. Anticancer Res, 32, 397-404.
- Preuss SF, Weinell A, Molitor M, et al (2008). Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma. Head Neck, 30, 1318-24. https://doi.org/10.1002/hed.20876
- Ryan BM, Konecny GE, Kahlert S, et al (2006). Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol, 17, 597-604. https://doi.org/10.1093/annonc/mdj121
- Seol JG, Park WH, Kim ES, et al (2001). Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells. Int J Oncol, 18, 249-55.
- Sica G, Lama G, Anile C, et al (2011). Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol, 38, 41-9.
- Span PN, Tjan-Heijnen VC, Manders P, et al (2006). High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast Cancer Res Treat, 98, 223-30. https://doi.org/10.1007/s10549-005-9153-0
- Suzuki A, Hayashida M, Ito T, et al (2000). Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene, 19, 3225-34. https://doi.org/10.1038/sj.onc.1203665
- Suzuki A, Ito T, Kawano H, et al (2000). Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene, 19, 1346-53. https://doi.org/10.1038/sj.onc.1203429
- Tamm I, Kornblau SM, Segall H, et al (2000). Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res, 6, 1796-803.
- Waligorska-Stachura J, Jankowska A, Wasko R, et al (2012). Survivin-- prognostic tumor biomarker in human neoplasms--review. Ginekol Pol, 83, 537-40.
- Yu JQ, Bao W, Lei JC (2012). Emodin regulates apoptotic pathway in human liver cancer cells. Phytother Res. doi:10.1002/ptr.4703.
- Zhang LQ, Wang J, Jiang F, et al (2012). Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis. PLoS One, 7, e34100. https://doi.org/10.1371/journal.pone.0034100
-
Zheng WE, Chen H, Yuan SF, et al (2012). Overexpression of
${\beta}$ III-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer. J BUON, 17, 284-90.
Cited by
- Targeted Silencing of Inhibitors of Apoptosis Proteins with siRNAs: A Potential Anti-cancer Strategy for Hepatocellular Carcinoma vol.14, pp.9, 2013, https://doi.org/10.7314/APJCP.2013.14.9.4943
- Clinicopathological and Prognostic Significance of Survivin Expression in Patients with Oral Squamous Cell Carcinoma: Evidence from a Meta-Analysis vol.10, pp.2, 2015, https://doi.org/10.1371/journal.pone.0116517
- An in silico Appraisal to Identify High Affinity Anti-Apoptotic Synthetic Tetrapeptide Inhibitors Targeting the Mammalian Caspase 3 Enzyme vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10137
- Molecular Pathology Signatures in Predicting Malignant Potentiality of Dysplastic Oral Pre-cancers vol.3, pp.2, 2015, https://doi.org/10.1007/s40362-015-0033-7
- Does Notch play a tumor suppressor role across diverse squamous cell carcinomas? vol.5, pp.8, 2016, https://doi.org/10.1002/cam4.731
- Impacts of survivin and caspase-3 on apoptosis and angiogenesis in oral cancer vol.14, pp.3, 2017, https://doi.org/10.3892/ol.2017.6626
- Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma vol.7, pp.2046-1402, 2018, https://doi.org/10.12688/f1000research.14856.2
- Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma vol.7, pp.2046-1402, 2018, https://doi.org/10.12688/f1000research.14856.1
- Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma vol.7, pp.2046-1402, 2018, https://doi.org/10.12688/f1000research.14856.3
- Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma vol.7, pp.2046-1402, 2019, https://doi.org/10.12688/f1000research.14856.4